Work

Comparative Effectiveness and Safety of Anti–Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn’s Disease

Year: 2016

Type: article

Study design: Observational Study

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2016.03.038

Authors: Siddharth Singh, Herbert C. Heien, Lindsey R. Sangaralingham, Stephanie R. Schilz, Michael D. Kappelman, Nilay D. Shah, Edward V. Loftus

Institutions: Mayo Clinic, University of California San Diego, University of North Carolina at Chapel Hill

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Center for Advancing Translational Sciences

Award: Mayo Clinic Center for Clinical and Translational Science (CCaTS)

OpenAlex ID: W2335895559

FWCI: 8.877

Cites: 19

Cited by: 69

Related to: 10